The FomA porin from Fusobacterium nucleatum is a toll-like receptor 2 agonist with immune adjuvant activity

Clinical and Vaccine Immunology

Volumn 19, Issue 7, 2012, Pages 1093-1101

  Toussi, Deana N ^a   Liu, Xiuping ^a   Massari, Paola ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; FOMA PROTEIN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; IMMUNOGLOBULIN M; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL SURFACE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FUSOBACTERIUM NUCLEATUM; GEL ELECTROPHORESIS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOREACTIVITY; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DYNAMICS; MONOTHERAPY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES; ANTIGENS, CD86; BACTERIAL OUTER MEMBRANE PROTEINS; CELLS, CULTURED; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MICE; MICE, INBRED C57BL; NF-KAPPA B; OVALBUMIN; TOLL-LIKE RECEPTOR 2;

EID: 84863555191     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00236-12     Document Type: Article

References (67)

1. Akira S, Takeda K, Kaisho T. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-680. (Pubitemid 32747155)
2. Alurkar V, Kamat R. 1997. Immunomodulatory properties of porins of some members of the family Enterobacteriaceae. Infect. Immun. 65:2382-2388. (Pubitemid 27237324)
3. Anbazhagan V, Vijay N, Kleinschmidt JH, Marsh D. 2008. Protein-lipid interactions with Fusobacterium nucleatum major outer membrane protein FomA: spin-label EPR and polarized infrared spectroscopy. Biochemistry 47:8414-8423.
4. Asong J, Wolfert MA, Maiti KK, Miller D, Boons GJ. 2009. Binding and cellular activation studies reveal that Toll-like receptor 2 can differentially recognize peptidoglycan from Gram-positive and Gram-negative bacteria. J. Biol. Chem. 284:8643-8653.
5. Babu MM, et al. 2006. A database of bacterial lipoproteins (DOLOP) with functional assignments to predicted lipoproteins. J. Bacteriol. 188:2761-2773.
6. Bakken V, Aaro S, Jensen HB. 1989. Purification and partial characterization of a major outer-membrane protein of Fusobacterium nucleatum. J. Gen. Microbiol. 135:3253-3262. (Pubitemid 20034306)
7. Bauer S, et al. 2001. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. U. S. A. 98:9237-9242. (Pubitemid 32743900)
8. Biswas A, Banerjee P, Biswas T. 2009. Porin of Shigella dysenteriae directly promotes toll-like receptor 2-mediated CD4+ T cell survival and effector function. Mol. Immunol. 46:3076-3085.
9. Bolstad AI, Jensen HB, Bakken V. 1996. Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum. Clin. Microbiol. Rev. 9 :55-71. (Pubitemid 26035539)
10. Bolstad AI, Tommassen J, Jensen HB. 1994. Sequence variability of the 40-kDa outer membrane proteins of Fusobacterium nucleatum strains and a model for the topology of the proteins. Mol. Gen. Genet. 244:104-110. (Pubitemid 24216925)
11. Brewer JM, et al. 1999. Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling. J. Immunol. 163:6448-6454.
12. Burke JM, Ganley-Leal LM, Khatri A, Wetzler LM. 2007. Neisseria meningitidis PorB, a TLR2 ligand, induces an antigen-specific eosinophil recall response: potential adjuvant for helminth vaccines? J. Immunol. 179:3222-3230.
13. Cervantes-Barragan L, et al. 2009. TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens. Eur. J. Immunol. 39:126-135.
14. Chiavolini D, Weir S, Murphy JR, Wetzler LM. 2008. Neisseria meningitidis PorB, a Toll-like receptor 2 ligand, improves the capacity of Francisella tularensis lipopolysaccharide to protect mice against experimental tularemia. Clin. Vaccine Immunol. 15:1322-1329.
15. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274:10689-10692.
16. Connell TD, Metzger D, Sfintescu C, Evans RT. 1998. Immunostimulatory activity of LT-IIa, a type II heat-labile enterotoxin of Escherichia coli. Immunol. Lett. 62:117-120. (Pubitemid 28332937)
17. Diehl S, Rincon M. 2002. The two faces of IL-6 on Th1/Th2 differentiation. Mol. Immunol. 39:531-536. (Pubitemid 35341492)
18. DiRienzo JM, Rosan B. 1984. Isolation of a major cell envelope protein from Fusobacterium nucleatum. Infect. Immun. 44:386-393. (Pubitemid 14139003)
19. Fisette PL, Ram S, Andersen JM, Guo W, Ingalls RR. 2003. The Lip lipoprotein from Neisseria gonorrhoeae stimulates cytokine release and NF-kappaB activation in epithelial cells in a Toll-like receptor 2-dependent manner. J. Biol. Chem. 278:46252-46260. (Pubitemid 37452195)
20. Fusco PC, Michon F, Tai JY, Blake MS. 1997. Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primates. J. Infect. Dis. 175:364-372. (Pubitemid 27052242)
21. Galdiero M, et al. 2004. Haemophilus influenzae porin induces Toll-like receptor 2-mediated cytokine production in human monocytes and mouse macrophages. Infect. Immun. 72:1204-1209. (Pubitemid 38166712)
22. Goriely S, Neurath MF, Goldman M. 2008. How microorganisms tip the balance between interleukin-12 family members. Nat. Rev. Immunol. 8:81-86.
23. Haake SK, Wang X. 1997. Cloning and expression of FomA, the major outer-membrane protein gene from Fusobacterium nucleatum T18. Arch. Oral Biol. 42:19-24. (Pubitemid 27311123)
24. Hajishengallis G, et al. 2005. Toll-like receptor 2 mediates cellular activation by the B subunits of type II heat-labile enterotoxins. Infect. Immun. 73:1343-1349. (Pubitemid 40470719)
25. Hayashi F, et al. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410:1099-1103. (Pubitemid 32391041)
26. Holmgren J, et al. 2005. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol. Lett. 97:181-188. (Pubitemid 40326949)
27. Huang GT, Zhang HB, Dang HN, Haake SK. 2004. Differential regulation of cytokine genes in gingival epithelial cells challenged by Fusobacterium nucleatum and Porphyromonas gingivalis. Microb. Pathog. 37:303-312. (Pubitemid 40037560)
28. Jensen HB, et al. 1996. Cloning of the fomA gene, encoding the major outer membrane porin of Fusobacterium nucleatum ATCC10953. Microb. Pathog. 21:331-342. (Pubitemid 26387319)
29. Ji S, et al. 2009. Toll-like receptor 2 and NALP2 mediate induction of human beta-defensins by Fusobacterium nucleatum in gingival epithelial cells. Infect. Immun. 77:1044-1052.
30. Kaisho T, Akira S. 2002. Toll-like receptors as adjuvant receptors. Biochim. Biophys. Acta 1589:1-13. (Pubitemid 34242898)
31. Kang JY, et al. 2009. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 31:873-884.
32. Karpathy SE, et al. 2007. Genome sequence of Fusobacterium nucleatum subspecies polymorphum - a genetically tractable fusobacterium. PLoS One 2:e659. doi:10.1371/journal.pone.0000659.
33. Kikkert R, Laine ML, Aarden LA, van Winkelhoff AJ. 2007. Activation of toll-like receptors 2 and 4 by gram-negative periodontal bacteria. Oral Microbiol. Immunol. 22:145-151. (Pubitemid 46683962)
34. Kim TG, et al. 2009. Immunogenicity of a cholera toxin B subunit Porphyromonas gingivalis fimbrial antigen fusion protein expressed in E. coli. Mol. Biotechnol. 41:157-164.
35. Kleinschmidt JH. 2006. Folding kinetics of the outer membrane proteins OmpAandFomAinto phospholipid bilayers.Chem.Phys. Lipids 141:30-47. (Pubitemid 43744430)
36. Kleivdal H, Benz R, Tommassen J, Jensen HB. 1999. Identification of positively charged residues of FomA porin of Fusobacterium nucleatum which are important for pore function. Eur. J. Biochem. 260:818-824. (Pubitemid 29148649)
37. Kleivdal H, Puntervoll P, Jensen HB. 2001. Topological investigations of the FomA porin from Fusobacterium nucleatum and identification of the constriction loop L6. Microbiology 147:1059-1067. (Pubitemid 32401345)
38. Krisanaprakornkit S, et al. 2000. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect. Immun. 68:2907-2915. (Pubitemid 30253871)
39. Lee CH, Masso-Welch P, Hajishengallis G, Connell TD. 2011. TLR2-dependent modulation of dendritic cells by LT-IIa-B5, a novel mucosal adjuvant derived from a type II heat-labile enterotoxin. J. Leukoc. Biol. 90:911-921.
40. Liu PF, et al. 2010. Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: Implication for treatment of periodontal infection and halitosis. Vaccine 28:3496-3505.
41. Liu X, Wetzler LM, Massari P. 2008. The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant. Vaccine 26:786-796.
42. Mackinnon FG, et al. 1999. The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porin. J. Infect. Dis. 180:755-761. (Pubitemid 29411362)
43. Marcato LG, et al. 2008. The role of Toll-like receptors 2 and 4 on reactive oxygen species and nitric oxide production by macrophage cells stimulated with root canal pathogens. Oral Microbiol. Immunol. 23:353-359.
44. Martin RM, Brady JL, Lew AM. 1998. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J. Immunol. Methods 212:187-192. (Pubitemid 28288356)
45. Massari P, et al. 2002. Cutting edge: immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent. J. Immunol. 168:1533-1537. (Pubitemid 34135744)
46. Massari P, King CA, Macleod H, Wetzler LM. 2005. Improved purification of native meningococcal porin PorB and studies on its structure/function. Protein Expr. Purif. 44:136-146. (Pubitemid 41565562)
47. Massari P, et al. 2006. Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling. J. Immunol. 176:2373-2380. (Pubitemid 43201686)
48. Medzhitov R, Janeway C, Jr. 2000. The Toll receptor family and microbial recognition. Trends Microbiol. 8:452-456.
49. Mosmann TR, Coffman RL. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173. (Pubitemid 19138011)
50. Nakagaki H, et al. 2010. Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptide. Infect. Immun. 78:1185-1192.
51. Peyret-Lacombe A, Brunel G, Watts M, Charveron M, Duplan H. 2009. TLR2 sensing of F. nucleatum and S. sanguinis distinctly triggered gingival innate response. Cytokine 46:201-210.
52. Pocanschi CL, et al. 2006. The major outer membrane protein of Fusobacterium nucleatum (FomA) folds and inserts into lipid bilayers via parallel folding pathways. J. Mol. Biol. 355:548-561. (Pubitemid 41785756)
53. Puntervoll P, et al. 2000. The Fusobacterium nucleatum porin FomA possesses the general topology of the non-specific porins. Microbiology 146(Pt 6):1437-1445. (Pubitemid 30364734)
54. Puntervoll P, et al. 2002. Structural characterization of the fusobacterial non-specific porin FomA suggests a 14-stranded topology, unlike the classical porins. Microbiology 148:3395-3403. (Pubitemid 35414451)
55. Qi HL, Tai JY, Blake MS. 1994. Expression of large amounts of neisserial porin proteins in Escherichia coli and refolding of the proteins into native trimers. Infect. Immun. 62:2432-2439. (Pubitemid 24157074)
56. Rao J, Seshagiri PB, Shetty G, Ramesh G, Adiga PR. 2000. Active immunization against riboflavin carrier protein results in peri-implantation embryonic loss leading to pregnancy termination in rats: use of alternate adjuvants. Indian J. Exp. Biol. 38:863-872.
57. Ray A, Biswas T. 2005. Porin of Shigella dysenteriae enhances Toll-like receptors 2 and 6 of mouse peritoneal B-2 cells and induces the expression of immunoglobulin M, immunoglobulin G2a and immunoglobulin A. Immunology 114:94-100. (Pubitemid 40030297)
58. Ray A, Karmakar P, Biswas T. 2004. Up-regulation of CD80-CD86 and IgA on mouse peritoneal B-1 cells by porin of Shigella dysenteriae is Toll-like receptors 2 and 6 dependent. Mol. Immunol. 41 : 1167-1175. (Pubitemid 39346265)
59. Re F, Strominger JL. 2001. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 276:37692-37699.
60. Shimazu R, et al. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1777-1782. (Pubitemid 29272694)
61. Singleton TE, Massari P, Wetzler LM. 2005. Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent. J. Immunol. 174:3545-3550. (Pubitemid 40354063)
62. Takada H, et al. 1988. Immunobiological activities of a porin fraction isolated from Fusobacterium nucleatum ATCC 10953. Infect. Immun. 56:855-863. (Pubitemid 18094837)
63. Takeuchi O, et al. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 11:443-451. (Pubitemid 29504199)
64. van der Ley P, Heckels JE, Virji M, Hoogerhout P, Poolman JT. 1991. Topology of outer membrane porins in pathogenic Neisseria spp. Infect. Immun. 59:2963-2971.
65. Wetzler LM. 2010. Innate immune function of the neisserial porins and the relationship to vaccine adjuvant activity. Future Microbiol. 5:749-758.
66. Wetzler LM, Ho Y, Reiser H. 1996. Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J. Exp. Med. 183:1151-1159. (Pubitemid 26113978)
67. Yoshimura A, Kaneko T, Kato Y, Golenbock DT, Hara Y. 2002. Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human toll-like receptor 4. Infect. Immun. 70:218-225. (Pubitemid 34028621)